secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001193125-26-104204
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics files $25M ATM equity offering via Jefferies
-----------------------------------------------------------------

- Filed prospectus supplement to sell up to $25M common stock under existing Sales Agreement with Jefferies LLC.
- Offering supplements prior $75M capacity; shares sold from time to time at market prices.
- Legal opinion from Morgan, Lewis & Bockius LLP filed as Exhibit 5.1.
- Proceeds intended for general corporate purposes; no specific use disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000119312526104204/0001193125-26-104204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000119312526104204/d916869d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-104204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer